Crossmark

Real-world Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection Not Associated with Cystic Fibrosis: A Comparative Analysis From the INBREATHING Registry

Crossref DOI link: https://doi.org/10.1016/j.arbres.2026.03.012

Published Print: 2026-10

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Raboso Moreno, Beatriz

Sánchez Villar, Carlos

Calero, Carmen

Erro, Marta

Alvarado-Miranda, Mariela

Llopis Pastor, Estefanía

Baran, Ezequiel

Esteban, Violeta

Diab Cáceres, Layla

Pou, Cristina

Zamarrón, Ester

Prados Sánchez, María Concepción

Pomares, Xavier

Montón, Concepción

Urrutia-Royo, Blanca

Lores, Carmen

Llopis Pitarch, Joan

Girón, Rosa

Sayés, Alicia

García-Urrestarazu, Eduardo J.

Belén Alcaide, Ana

Costa, Roser

Vidal Ortola, Martha

Santisteve, Sally

Manzano, Carlos

Monge, Aida

Benítez, Iván D.

Moncusí-Moix, Anna

Sánchez-Cucó, Anna

Morales, Arturo

Abril Castañon, Rosa

Navarro, Annie

Lakhani, Joel-Suresh

de-Torres, Juan P.

Suarez-Cuartín, Guillermo

de la Rosa, David

Gracia-Lavedan, Esther

González, Jessica
Funding

Funding for this research was provided by:

Gruppo Chiesi

Generalitat de Catalunya Departament de Salut
License Information

Text and Data Mining valid from 2026-10-01

Text and Data Mining valid from 2026-10-01

Version of Record valid from 2026-04-23
More Information

This article is maintained by: Elsevier

Article Title: Real-world Outcomes of Nebulized Levofloxacin in Chronic Bronchial Infection Not Associated with Cystic Fibrosis: A Comparative Analysis From the INBREATHING Registry

Journal Title: Archivos de Bronconeumología

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbres.2026.03.012

Content Type: simple-article

Copyright: © 2026 The Author(s). Published by Elsevier España, S.L.U. on behalf of SEPAR.

Document is current

Any future updates will be listed below